May 8, 2019 / 2:25 PM / 15 days ago

Bill backed by generic drug companies gets PhRMA endorsement at Senate hearing

The Pharmaceutical Research and Manufacturers of America (PhRMA) now supports a bill it previously opposed that would help generic drug companies obtain samples they need to bring products to market, a representative of the trade association said at a U.S. Senate hearing on Tuesday.

James Stansel, PhRMA’s general counsel, testifying before the Senate Judiciary Committee’s subcommittee on intellectual property said the trade organization does not oppose a Senate bill known as the CREATES Act that would allow developers of generic drugs to bring civil lawsuits against manufacturers of brand-name drugs if insufficient quantities of samples are made available for premarket testing.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below